Cargando…
Efficacy and Safety of Low-dose Oral Prednisolone for Patients with Refractory Hunner-type Interstitial Cystitis
BACKGROUND: Hunner-type interstitial cystitis (HIC) is an immunological, chronic inflammatory disease. The efficacy of corticosteroid as a treatment for HIC is unclear. OBJECTIVE: To assess the efficacy and safety of low-dose oral prednisolone (PSL) treatment for patients with refractory HIC. DESIGN...
Autores principales: | Akiyama, Yoshiyuki, Niimi, Aya, Nomiya, Akira, Taguchi, Satoru, Yamada, Yuta, Sato, Yusuke, Yamada, Daisuke, Maeda, Daichi, Ushiku, Tetsuo, Kume, Haruki, Homma, Yukio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562155/ https://www.ncbi.nlm.nih.gov/pubmed/37822513 http://dx.doi.org/10.1016/j.euros.2023.07.006 |
Ejemplares similares
-
Deep Learning Models for Cystoscopic Recognition of Hunner Lesion in Interstitial Cystitis
por: Iwaki, Takuya, et al.
Publicado: (2023) -
Relationship between the frequency of electrocautery of Hunner lesions and changes in bladder capacity in patients with Hunner type interstitial cystitis
por: Akiyama, Yoshiyuki, et al.
Publicado: (2021) -
Increased CXCR3 Expression of Infiltrating Plasma Cells in Hunner Type Interstitial Cystitis
por: Akiyama, Yoshiyuki, et al.
Publicado: (2016) -
Genome-wide association study identifies risk loci within the major histocompatibility complex region for Hunner-type interstitial cystitis
por: Akiyama, Yoshiyuki, et al.
Publicado: (2023) -
Th1/17 polarization and potential treatment by an anti-interferon-γ DNA aptamer in Hunner-type interstitial cystitis
por: Akiyama, Yoshiyuki, et al.
Publicado: (2023)